How cancer cells loose their (Circadian) rhythm

Key points
- Immortality and uncontrolled cell division are the fundamental differences between cancer cells and normal cells.
- A widely held explanation for these differences is that the biological clocks in cancer cells are damaged and can't regulate cell division in the fashion that they do in normal cells.
- This assumption is challenged by the results of the first experiment that has continuously monitored variations in the rate of cell division of cultured mammalian cells for extended periods.
- The experiment discovered that one line of immortal cells have functioning biological clocks but their internal clocks have no effect on the rate at which they divide and grow.
Immortality and uncontrolled cell division are the fundamental differences between cancer cells and normal cells.
A widely held explanation for these differences is that the biological clocks in cancer cells are damaged and can't regulate cell division in the fashion that they do in normal cells.
This assumption is challenged by the results of the first experiment that has continuously monitored variations in the rate of cell division of cultured mammalian cells for extended periods. The results are reported this week in a paper published in the online Early Edition of the Proceedings of the National Academy of Sciences.
The experiment discovered that one line of immortal cells have functioning biological clocks but their internal clocks have no effect on the rate at which they divide and grow. (Immortal cells have the same basic properties as cancer cells but are created in the laboratory where they are used for a wide variety of purposes.)
"The current assumption has been that the biological clocks in cancer cells have been disabled," says Julie Pendergast, a research associate who participated in the study. "We determined that the immortalized cells in our experiment had functioning biological clocks but these clocks don't control the process of cell division. That is the paradigm shifting aspect of our study."
If confirmed by follow-up studies, this insight could aid in the development of new cancer therapies.
"This strengthens the possibility that the biological clock pathway could be an effective target for anti-cancer drugs," says Shin Yamazaki, the research professor of biological sciences at Vanderbilt who directed the project. "For example, if a drug could be found that restores the control of the biological clock over cancer cell division, it could reduce tumor growth."
Biologists have observed that cell division in normal cells in species ranging from unicellular organisms to humans peaks at specific times of the day and consider this as indirect evidence that the process is regulated by their internal biological clocks. Cells in the human mouth, for example, tend to divide in the evening, just before nightfall.
"There is a general evolutionary explanation for this," says research associate Julie Pendergast who participated in the study. "Ultraviolet light is one of the primary causes of mutations. Cells are particularly vulnerable to mutations during cell division. So organisms with cells that divide at night have a selective advantage."
In addition, there has been a considerable amount of indirect evidence that mitosis (division) in cancer cells is not under 24-hour control. For example, "experiments have found that cells turn cancerous when certain circadian clock genes have been knocked out," says Yamazaki. The results of other experiments that have periodically sampled cancer cell division rates also support this possibility.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew finding points to potential options for attacking stem cells in triple-negative breast cancer
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an…
18 February 2014
NewsProstate cancer signal reawakens 'sleeper agent' cells in bones
Dormant prostate cancer cells in bone tissue can be reawakened to cause secondary tumours, according to new research published in Endocrine-Related Cancer. Targeting the wake-up call could prevent metastasis and improve…
30 January 2014
NewsLong-lived breast stem cells could retain cancer legacy
Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty and throughout…
27 January 2014






